Explain this page
Arphra AIPlain-English read on HCA Healthcare, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00% | -6.20% | -14.35% | -29.97% | -26.25% | -20.54% | -2.93% | +38.49% | +71.84% | +373.34% | +1095.87% |
Aftermarket
LiveLast trade
$375.63
94 sh
Bid
$370.87
3 sh
Ask
$377.00
200 sh
Spread
$6.130
Sector & industry today
LiveSectors
- Technology+3.30%
- Basic Materials+0.98%
- Energy+0.83%
- Consumer Cyclical+0.49%
- Industrials+0.25%
- Communication Services+0.13%
- Healthcare-0.65%
- Financial Services-0.80%
- Consumer Defensive-0.84%
- Utilities-1.15%
- Real Estate-1.32%
Top industries (issuer's industry highlighted)
- Medical - Care Facilities-0.25%
- Computer Hardware+8.35%
- Software - Infrastructure+7.61%
- Consulting Services+5.28%
- Coal+5.20%
- Manufacturing - Metal Fabrication+4.24%
- Staffing & Employment Services+4.08%
- Gambling, Resorts & Casinos+3.71%
- Broadcasting+3.70%
- Integrated Freight & Logistics+3.68%
- REIT - Healthcare Facilities-3.49%
- Software - Application+3.44%
Fair value
Football field →Weighted blend
$1,526.04
+311.38% vs spot
Recommendation
Strong Buy
16 of 18 methods
Method spread
8bull7bear
±5% threshold
Analyst PT consensus: $527.45 (+42.19%)
Total assets
$60.72B
Total debt
$50.2B
Cash & equiv
$1.04B
Operating CF
$12.64B
Free cash flow
$7.69B
Buybacks
-$10.07B
Analyst view
DB · price_targets + analyst_gradesConsensus target
$527.45
+42.19% upside
Low
$436.00
Median
$530.00
High
$635.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $19.11B | $1.62B | $7.15 |
| Q4 Dec 2025 | $19.51B | $1.88B | $8.14 |
| Q3 Sep 2025 | $19.16B | $1.64B | $6.96 |
| Q2 Jun 2025 | $18.61B | $1.65B | $6.83 |
| Q1 Mar 2025 | $18.32B | $1.61B | $6.45 |
| Q4 Dec 2024 | $18.29B | $1.44B | $5.63 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
McAlevey Michael R officer: EVP & Chief Legal & Admin Off. | Sell | 1,694 | $903.54K | Feb 18, 2026 |
Wyatt Christopher F. officer: SVP & Controller | Sell | 4,000 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.11M | Feb 11, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 5,162 | $2.57M | Feb 03, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 14,716 | $7.4M | Feb 03, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $75.6B | $11.97B | $6.78B | $28.38 | +8.97% |
| FY 2024 | $70.6B | $10.55B | $5.76B | $22.00 | +8.16% |
| FY 2023 | $64.97B | $9.63B | $5.24B | $18.96 | +8.07% |
| FY 2022 | $60.23B | $9.05B | $5.64B | $19.15 | +9.37% |
| FY 2021 | $58.75B | $9.68B | $6.96B | $21.16 | +11.84% |